Smith & Nephew plc (SN.L)
Makes surgical implants and wound care products for orthopedic and trauma procedures.
1,200.00+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+3.8%
The outlook
Smith & Nephew is trading near the upper end of its 52-week range, with the average analyst target sitting about 15% above the current price. The stock shows mixed momentum against its moving averages, while analyst sentiment leans bullish overall. At a trailing P/E of 22.2, it sits at a moderate valuation level.
What’s behind the score
Price trendMixed vs its moving averages
52-week range83% of the way from its 52-week low to high
Price targetAvg target +15% vs current price
Analyst price target
~12-month · 17 analysts1,375.65average target+14.6% vs now
Now 1,200.00
Low 1,198.78High 1,561.46
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$10.10B
52-wk high
1,441.50
52-wk low
0.00
50-day avg
1,132.22
200-day avg
1,218.40
Trailing P/E
22.2